Similar articles

• Asenapine.

  Meltzer HY, Dritselis A, Yasothan U, Kirkpatrick P. Meltzer HY, et al. Nat Rev Drug Discov. 2009 Nov;8(11):843-4. doi: 10.1038/nrd3027. Nat Rev Drug Discov. 2009. PMID: 19876039
• Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.

  Fagiolini A, Forgione RN, Morana B, Maccari M, Goracci A, Bossini L, Pellegrini F, Cuomo A, Casamassima F. Fagiolini A, et al. Expert Opin Pharmacother. 2013 Mar;14(4):489-504. doi: 10.1517/14656566.2013.765859. Epub 2013 Jan 29. Expert Opin Pharmacother. 2013. PMID: 23356509 Review.
• New drug information. Saphris.

  Physician Assistants Prescribing Reference. Physician Assistants Prescribing Reference. JAAPA. 2010 Mar;23(3):16. JAAPA. 2010. PMID: 20232719 No abstract available.
• Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder.

  Kemp DE, Zhao J, Cazorla P, Landbloom RP, Mackle M, Snow-Adami L, Szegedi A. Kemp DE, et al. J Clin Psychiatry. 2014 Mar;75(3):238-45. doi: 10.4088/JCP.12m08271. J Clin Psychiatry. 2014. PMID: 24499969
• A Review of Asenapine in the Treatment of Bipolar Disorder.

  Vieta E, Montes JM. Vieta E, et al. Clin Drug Investig. 2018 Feb;38(2):87-99. doi: 10.1007/s40261-017-0592-2. Clin Drug Investig. 2018. PMID: 29067671 Free PMC article. Review.